Abstract:α-Amylase (AA) inhibitory peptides are a new class of anti-diabetic therapeutic agents. A high number of peptides with different amino acid sequences were identified by researchers. However, the mechanism and the properties of the peptides are yet to be explored. In this review, AA inhibitory peptides were randomly chosen from the BioPEP-UWM database and recent publications. Subsequently, they were categorized into three groups (i.e. short peptide (SP), medium peptide (MP) and long peptide (LP)) based on the peptide length, followed by evaluation based on structure-activity relationship by using in silico approach. The AA hotspots were initially reviewed from the SAR analysis result, and found that four substrate analogues (Trp58, Trp59, Tyr62 and His299) and one catalytic residue (Asp300) were highly bound by these peptides, in general. However, the peptide length played a crucial factor in which SP has one less preferred hotspot (His299), whereas LP showed 2 additional hotspots more (Asp96 and Arg195). When reviewing the properties of the peptides, it was found that these peptides were highly hydrophobic, which contained amino acids with aliphatic side chains, followed by polar neutral regardless of peptide length. In general, proline, leucine, and serine were the top 3 reactive amino acid residues in the peptides. However, different prevalent amino acids were found in SP (proline, leucine and serine), MP (proline and leucine) and LP (glutamine, alanine and serine). When the terminal positions (i.e. ultimate (N1 and C1), penultimate (N2 and C2) and antepenultimate (N3 and C3) positions) were assessed, the data showed different preferences in the amino acid residues based on the peptide length. The details of interaction were also elaborated in this review based on the molecular docking analysis, in which hydrophobic interactions, salt bridges and hydrogen bonds were involved. In conclusion, this review provided the way of identifying the AA inhibitory peptides and offered fundamental and practical information for designing or discovering the peptide-based AA inhibitory agent.

Collagen derived Gly-Pro-type DPP-IV inhibitory peptides: Structure-activity relationship, inhibition kinetics and inhibition mechanism

Molecular Mechanistic Insights into Dipeptidyl Peptidase-IV Inhibitory Peptides to Decipher the Structural Basis of Activity

Exploring structural features of potent dipeptidyl peptidase IV (DPP-IV) inhibitory peptides derived from tilapia (Oreochromis niloticus) skin gelatin by an integrated approach of multivariate analysis and Gly-Pro-based peptide library

Identification of dipeptidyl peptidase-IV inhibitory peptides from yak bone collagen by in silico and in vitro analysis

Food-derived dipeptidyl peptidase IV inhibitory peptides: Production, identification, structure-activity relationship, and their potential role in glycemic regulation

Study on the Mechanism of Interaction between Dipeptidyl Peptidase 4 and Inhibitory Peptides Based on Gaussian Accelerated Molecular Dynamic Simulation

Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity

Preparation, structural properties, and in vitro and in vivo activities of peptides against dipeptidyl peptidase IV (DPP-IV) and α-glucosidase: a general review

Statistical Characterization of Food-Derived α-Amylase Inhibitory Peptides: Computer Simulation and Partial Least Squares Regression Analysis

Strategic Preparations of DPP-IV Inhibitory Peptides from Val-Pro-Xaa and Ile-Pro-Xaa Peptide Mixtures

Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides

Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.

Unveiling α-Amylase Inhibition: A Bioinformatics Perspective on Peptide Properties and Amino Acid Contributions

Peptide array screening with anti-GLP-1 monoclonal antibody: Discovery of cysteine-containing DPP-IV inhibitory peptides

Synthesis of Novel Potent Dipeptidyl Peptidase IV Inhibitors with Enhanced Chemical Stability: Interplay Between the N-terminal Amino Acid Alkyl Side Chain and the Cyclopropyl Group of Alpha-Aminoacyl-l-cis-4,5-methanoprolinenitrile-based Inhibitors.

Design, Synthesis and Biological Evaluation of Novel Imidazolone Derivatives As Dipeptidyl Peptidase 4 Inhibitors.

Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects

Identification, Screening, and Comprehensive Evaluation of Novel DPP-IV Inhibitory Peptides from the Tilapia Skin Gelatin Hydrolysate Produced Using Ginger Protease

Preparation, characterization, and mechanism of DPP-IV inhibitory peptides derived from Bactrian camel milk

High accuracy prediction of dipeptide angiotensin-converting enzyme (ACE) inhibitory activity by improving the credibility of the 3D-quantitative structure-activity relationship (3D-QSAR) model database and investigating inhibition mechanism

Structure-activity relationships study on biological activity of peptides as dipeptidyl peptidase IV inhibitors by chemometric modeling